Treatment of mood and anxiety disorders
US8513195B2 · kind B2 · utility
0Cited by
0References
4Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 2, 2009 |
| Grant date | Aug 20, 2013 |
| Priority date | — |
| Expiry date | Oct 2, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a selective inhibitor of Elk-1 or MSK-1 activation for use in the prevention and/or treatment of mood and anxiety disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.